Toggle navigation
About Us
Portfolio
News
Contact Us
Lightchain Capital
Recent News
April 12, 2021
CareVet Challenges Industry to Adopt $15/hr Minimum Pay
READ MORE
April 10, 2021
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
READ MORE
April 09, 2021
Living wage initiative launched by national hospital network
READ MORE
April 01, 2021
Raising the Ante
READ MORE
March 25, 2021
The Development of Natural Killer Cells for Solid Tumor Treatment
READ MORE
March 17, 2021
Geneoscopy Appoints Don Hardison to its Strategic Advisory Board
READ MORE
March 11, 2021
Alpha Biopharma lands deal for Wugen’s memory NK and CAR T cells for Asia
READ MORE
March 11, 2021
C4 Therapeutics Reports Recent Business Highlights and Full Year 2020 Financial Results
READ MORE
March 10, 2021
C4 Therapeutics to Present on the Discovery and Preclinical Development of CFT7455, a MonoDAC™ Degrader Targeting IKZF1/3, at the American Association for Cancer Research (AACR) Annual Meeting
READ MORE
1
21
22
23
24
25
26
27
...
29
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4789,4811,4830,4819,4815,4760,4792,4760,4791,4825,4828,4817,4811,4824,4778,4825,4831,4830,4822,4825,4825,4821,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2024 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group
